Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2000
06/28/2000CN1258294A 2-oxoimidazole derivs.
06/28/2000CN1258283A Cyclic diamine compounds and medicine contg. same
06/28/2000CN1053898C Process for preparation of 2-{4-[4-(4-loro-1-pyrazolyl) butyl]-1-piperazinyl} pyrimidine
06/27/2000US6080873 Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
06/27/2000US6080870 Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
06/27/2000US6080784 A phorbol derivative used as antiinflammatory agent
06/27/2000US6080776 Used as a microbiocide for crop protection
06/27/2000US6080743 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
06/27/2000CA2017193C N-(aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a pro cess for their preparation and their use as medicaments
06/22/2000WO2000035920A2 4,5-azolo-oxindoles
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035909A1 4-aryloxindoles as inhibitors of jnk protein kinases
06/22/2000WO2000035908A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
06/22/2000WO2000035906A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000WO2000035887A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/22/2000CA2355249A1 Protease inhibitors
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354873A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
06/22/2000CA2354591A1 4-aryloxindoles as inhibitors of jnk protein kinases
06/22/2000CA2354510A1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000CA2349333A1 Vitronectin receptor antagonist pharmaceuticals
06/21/2000EP1009854A1 A method of treating cancer
06/21/2000EP1009770A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
06/21/2000EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
06/21/2000EP1009405A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
06/21/2000CN1053660C Process for preparing indole derivatives containing 1,2,4-triazol-1-yl substituents
06/20/2000US6077960 Uretedione derivative, curable resin composition comprising the same, and process for producing the same
06/20/2000US6077853 Inhibitors of farnesyl-protein transferase
06/20/2000US6077840 For treating or preventing progesterone-related diseases, for having an abortion, or for orally preventing conception, breast cancer, ovarian cancer, hysteromyoma, endometriosis, meningioma, myeloma, osteoporosis
06/20/2000US6077813 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
06/20/2000US6077812 Cycloimido-substituted benzofused heterocyclic herbicides
06/15/2000WO2000034437A2 Inhibitors of prenyl-protein transferase
06/15/2000WO2000034266A1 Indole derivatives and their use as 5-ht1f agonists
06/15/2000WO2000034255A1 Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin
06/15/2000WO2000033844A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
06/15/2000WO2000033836A1 5-membered heterocycles for the treatment of human diseases involving modulators of selectins
06/15/2000WO2000006531A3 Nitric esters and nitrate salts of specific drugs
06/15/2000DE19857202A1 New benzimidazolyl amidine or nitrile compounds, useful as thrombin inhibitors or antithrombotic agents, for treating deep leg vein thrombosis
06/15/2000CA2354040A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
06/14/2000EP1007729A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES
06/14/2000EP1007524A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
06/14/2000EP1007522A1 2- 4-[4-(4, 5-dichloro -2-methylimidazol-1-yl) butyl]-1-piperazinyl -5-fluoropyrimidine,preparation and therapeutic use
06/14/2000EP1007515A1 Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
06/14/2000EP1007513A1 Pesticidal 1-aryl-3-iminopyrazoles
06/14/2000EP1007056A1 Method for the treatment of cystic fibrosis
06/14/2000EP1007051A1 Integrin receptor antagonists
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/14/2000CN1256691A 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
06/14/2000CN1053438C Benzodiazepin-2-one derivatives, process for their prepn. and pharmaceutical composition containing them
06/13/2000USRE36736 Substituted pyrroles
06/13/2000US6075041 Cyclic amides
06/13/2000US6075040 Obesity and diabetes
06/13/2000US6075025 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
06/13/2000US6074989 Substituted azolylsulphonylphenyluracils
06/13/2000CA1341023C Peptide derivatives
06/08/2000WO2000032590A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
06/08/2000WO2000032589A1 Eletriptan hydrobromide monohydrate
06/08/2000WO2000032588A2 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000009103A9 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders
06/08/2000DE19956253A1 Piperazinonderivate Piperazinone
06/07/2000EP1006114A1 Pyrazole derivatives and cox inhibitors containing them
06/07/2000EP1006110A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
06/07/2000EP1005456A1 Method for producing organic compounds
06/07/2000EP1005454A1 2-acylaminopropanamines as tachykinin receptor antagonists
06/07/2000CN1053190C Quinoxalindione derivs, their prepn. and their used in drugs
06/06/2000US6072059 Heat development image forming process and heptamethine cyanine compound
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071947 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
06/06/2000US6071938 Benzopyrans
06/06/2000US6071931 AT1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
06/06/2000US6071921 4-phenyl-7-arylquinoazolines; angiogenisis inhibitors and/or vascular permeability reducing effects in warm-blooded animals; anticarcinogenic and -arthritic agents; rheumatic diseases; vascular endothelium growth factor inhibitors
06/06/2000US6071920 Bind to 5ht 1a receptors for treating disorders of the lower urinary tract; cns disorders; anxiolytic agents; antidepressants; hypotensive agents; sleep and eating disorders
06/06/2000US6071915 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
06/06/2000US6071913 2-(1h-tetrazol-5-yl)-4'-(as-triazin-ylmethyl)biphenyls; cardiovascular diseases, especially hypertension and congestive heart failure
06/06/2000US6071903 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
06/06/2000US6071900 Heterocyclic compounds and their use
06/06/2000US6071895 Polar-substituted hydrocarbons
06/06/2000US6071860 For selective control of broad-leaved and grass weeds in crops of useful plants
06/06/2000CA2198599C Salts of an anti-migraine indole derivative
06/02/2000WO2000031072A1 Process for making 5-substituted pyrazoles using dithietanes
06/02/2000WO2000031069A1 Piperazinone derivatives
06/02/2000WO2000031067A1 Propanoic acid derivatives as integrin inhibitors
06/02/2000WO2000031065A1 Compounds having cytokine inhibitory activity
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000WO2000031053A1 Il-5 inhibiting 6-azauracil derivatives
06/02/2000WO2000031051A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031050A1 Quinoline and quinoxaline compounds
06/02/2000WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031032A1 Pyrrolidine derivatives-ccr-3 receptor antagonists
06/02/2000WO2000030639A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
06/02/2000CA2352584A1 Quinoline and quinoxaline compounds
06/02/2000CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352526A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
06/02/2000CA2352261A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
06/02/2000CA2350969A1 Compounds having cytokine inhibitory activity
06/02/2000CA2350903A1 Pyrrolidine derivatives-ccr-3 receptor antagonists
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 626